ABIOMED's GAAP net income for fiscal year 2022 was $136.505 million, down 39.5% from $225.525 million in the previous year. Revenue increased 21.8% to $1.032 billion from $0.847 billion a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept